DNA News and Research

RSS

DNA, or deoxyribonucleic acid, is the hereditary material in humans and almost all other organisms. Nearly every cell in a person’s body has the same DNA. Most DNA is located in the cell nucleus (where it is called nuclear DNA), but a small amount of DNA can also be found in the mitochondria (where it is called mitochondrial DNA or mtDNA).

New COVID-19 vaccine promises vaccine equity because it has no patents

Corbevax, a new vaccine against COVID-19, may have better success as a candidate for vaccine equity because it carries no patents, relies on long-established recombinant technology for manufacture and has the support of the US and Indian governments, its makers and health experts say.

21 Jan 2022

Study explores whether gut bacteria profiles differ by race and insulin sensitivity status

In the present study published in PLOS ONE, researchers designed and undertook a unique study to investigate these interactions further.

21 Jan 2022

Fully dynamic kinetic model of a living 'minimal cell' offers insight into basic principles of life

Scientists report that they have built a living "minimal cell" with a genome stripped down to its barest essentials – and a computer model of the cell that mirrors its behavior.

20 Jan 2022

Researchers identify first known patients with BUB1 biallelic mutations

A new study published in Science Advances described the first two patients known to have mutations in both copies of BUB1, a critical gene for cell division.

20 Jan 2022

New cryo-EM method may be able to shortcut a big step in modern vaccine development

Scientists at Scripps Research have devised a method that may be able to shortcut one of the big steps in modern vaccine development.

20 Jan 2022

Prospective of graphene and graphene-based derivatives to combat SARS-CoV-2 infection

Researchers explored the utilities of graphene and its derivatives in combating SARS-CoV-2, highlighting its applications in the biomedical domain.

20 Jan 2022

Study identifies a new potential pathway for developing therapeutics against Epstein-Barr virus

A new study by researchers at The Wistar Institute, an international biomedical research leader in cancer, immunology, infectious disease, and vaccine development, has identified a new potential pathway for developing therapeutics that target Epstein-Barr virus (EBV).

19 Jan 2022

Novel antibody that targets the N-terminal domain of SARS-CoV-2 identified

A new study discusses the targeted discovery of NTD-reactive antibodies from an individual who had recovered from SARS-CoV-2 infection.

19 Jan 2022

Yale research sheds light on the lifespan and myriad functions of messenger RNAs

It took a global pandemic, but the critical role of messenger RNA in all of life's functions has taken center stage in the past year with the successful rollout of mRNA vaccines to combat the SARS-Cov-2 virus.

19 Jan 2022

Non-invasive, novel urinary miRNA biomarker panel for colorectal cancer diagnosis

Researchers set out to develop and validate urine biomarkers for diagnosing gastric cancer and colorectal cancer.

19 Jan 2022

Rapid DNA sequencing technique used to diagnose rare genetic disease in short time

A new ultra-rapid genome sequencing approach developed by Stanford Medicine scientists and their collaborators was used to diagnose rare genetic diseases in an average of eight hours — a feat that's nearly unheard of in standard clinical care.

19 Jan 2022

Contagious cancers can jump between marine clam species, study shows

A contagious blood cancer jumped from one species of clam to another and spread among clams living in the Atlantic Ocean and Mediterranean Sea, shows a study published today in eLife.

18 Jan 2022

MD Anderson and Eisbach Bio collaborate to develop precision oncology drugs

The University of Texas MD Anderson Cancer Center and Eisbach Bio GmbH today announced a strategic research collaboration to jointly discover and develop precision oncology drugs that target synthetic lethal engines key to tumor genome evolution.

18 Jan 2022

New pathways responsible for hepatocellular carcinoma identified

Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer. It is one of leading causes of cancer-related deaths globally, with more than 700,000 new cases and 600,000 estimated HCC deaths each year.

18 Jan 2022

Chinese scientists reveal key role of lysosome cell death regulator in lung tumor survival

Chinese scientists recently reported the key role of histone acetylation-regulated long noncoding RNA termed as lysosome cell death regulator (LCDR) in tumor survival, providing a potential diagnostic and therapeutic target for lung cancer.

18 Jan 2022

Applications of bioconjugated nanomaterials in SARS-CoV-2 diagnostics

In this study, the researchers not only elucidate the recent bioconjugated nanomaterials for targeted diagnosis of SARS-CoV-2, but they also provide the rationale behind these developments by discussing the mechanisms and approaches.

18 Jan 2022

New blood test for glioblastoma diagnosis may soon be a reality

Researchers at the University of Sussex are one step further to developing a blood test capable of diagnosing the most aggressive form of brain tumor.

18 Jan 2022

Earth BioGenome Project moves from pilot projects to full-scale sequencing

A global effort to map the genomes of all plants, animals, fungi and other microbial life on Earth, is entering a new phase as it moves from pilot projects to full-scale production sequencing.

18 Jan 2022

Topical antiseptic Acriflavine inhibits SARS-CoV-2 and other betacoronaviruses

A new study, published in the journal Cell Chemical Biology, has reported the discovery of acriflavine (ACF), an effective inhibitor of SARS-CoV-2. This drug is a mixture of trypaflavines (3,6-diamino-10-methylacridinium chloride and 3,6-diamino-3-methylacridinium chloride) and proflavine (3,6-diaminoacridine).

16 Jan 2022

Genome editing in vascular endothelial cells made possible with a powerful new delivery system

Northwestern Medicine scientists developed a unique nanoparticle to deliver genome editing technology, including CRISPR/Cas9, to endothelial cells, which line blood vessel walls.

16 Jan 2022

DNA News and Research

Further Reading

New COVID-19 vaccine promises vaccine equity because it has no patents

Study explores whether gut bacteria profiles differ by race and insulin sensitivity status

Fully dynamic kinetic model of a living 'minimal cell' offers insight into basic principles of life

Researchers identify first known patients with BUB1 biallelic mutations

New cryo-EM method may be able to shortcut a big step in modern vaccine development

Prospective of graphene and graphene-based derivatives to combat SARS-CoV-2 infection

Study identifies a new potential pathway for developing therapeutics against Epstein-Barr virus

Novel antibody that targets the N-terminal domain of SARS-CoV-2 identified

Yale research sheds light on the lifespan and myriad functions of messenger RNAs

Non-invasive, novel urinary miRNA biomarker panel for colorectal cancer diagnosis

Rapid DNA sequencing technique used to diagnose rare genetic disease in short time

Contagious cancers can jump between marine clam species, study shows

MD Anderson and Eisbach Bio collaborate to develop precision oncology drugs

New pathways responsible for hepatocellular carcinoma identified

Chinese scientists reveal key role of lysosome cell death regulator in lung tumor survival

Applications of bioconjugated nanomaterials in SARS-CoV-2 diagnostics

New blood test for glioblastoma diagnosis may soon be a reality

Earth BioGenome Project moves from pilot projects to full-scale sequencing

Topical antiseptic Acriflavine inhibits SARS-CoV-2 and other betacoronaviruses

Genome editing in vascular endothelial cells made possible with a powerful new delivery system

eBook: A guide to RNA sequencing eBook

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest Life Science News